Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Rationale and design of a clinical trial investigating resistance training as an aid to smoking cessation in persons with multiple sclerosis.
IL-17-Induced Act1-Mediated Signaling Is Critical for Cuprizone-Induced Demyelination.
Treatment with MOG-DNA vaccines induces CD4+CD25+FoxP3+ regulatory T cells and upregulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis.
[Change of treatment in patients with multiple sclerosis and its consequences in clinical practice].
[Association between polymorphisms of cytokine genes and the rate of multiple sclerosis progression.]
Neuromyelitis optica: Aquaporin-4 based pathogenesis mechanisms and new therapies.
P-glycoprotein regulates trafficking of CD8(+) T cells to the brain parenchyma.
A case of recurrent optic neuritis associated with cerebral and spinal cord lesions and autoantibodies against myelin oligodendrocyte glycoprotein relapsed after fingolimod therapy.
Successful treatment of fingolimod-associated macular edema with intravitreal triamcinolone with continued fingolimod use.
The Opioid System and Brain Development: Effects of Methadone on the Oligodendrocyte Lineage and the Early Stages of Myelination.
The flavonoid-enriched fraction AF4 suppresses neuroinflammation and promotes restorative gene expression in a mouse model of experimental autoimmune encephalomyelitis.
Brain MRI of nasal MOG therapeutic effect in relapsing-progressive EAE.
The intention to exercise and the execution of exercise among persons with multiple sclerosis - a qualitative metasynthesis.
Early recognition and diagnosis of multiple sclerosis.
Seasonality of multiple sclerosis and neuromyelitis optica exacerbations in Japan.
[Vitamin D tweets light to genes in multiple sclerosis].
Protective Effects of 7,8-Dihydroxyflavone on Retinal Ganglion and RGC-5 Cells Against Excitotoxic and Oxidative Stress.
A randomized clinical trial of valacyclovir in multiple sclerosis.
Disease Amelioration With Tocilizumab in a Treatment-Resistant Patient With Neuromyelitis Optica: Implication for Cellular Immune Responses.
Treatment of the chronic progressive form of multiple sclerosis with a combination of cyclophosphamide and prednisone.
Tumefactive demyelination: an approach to diagnosis and management.
A case of septal panniculitis secondary to interferon treatment.
Longitudinal study of alexithymia and multiple sclerosis.
History, applications, and mechanisms of deep brain stimulation.
Minoderm
Pages
« first
‹ previous
…
228
229
230
231
232
233
234
235
236
…
next ›
last »